ADVERUM BIOTECHNOLOGIES, INC. LETTERHEAD]Employment Agreement • June 20th, 2017 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This letter agreement (the “Agreement”) memorializes the employment terms for your anticipated hire by Adverum Biotechnologies, Inc. (the “Company”) in the position of Senior Vice President & Chief Medical Officer reporting to Amber Salzman, President & Chief Executive Officer. These terms will become effective on June 19, 2017, or at a later date determined by mutual agreement and approved by the Board of Directors of the Company (as applicable, the “Hire Date”).
ADVERUM BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 20th, 2017 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Athena Countouriotis, M.D. (“Executive”) and Adverum Biotechnologies, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
